iShares Nasdaq Biotechnology (IBB) – Nasdaq The best indicators for our biotech portfolios are the biotechnology indices IBB, NBI, XBI or XLV. We will maintain our focus on the IBB as the biotech barometer, which has suffered lately from an over exposure. It has been mentioned nonstop on any financial TV programs or investors reports, trying […]
April 8 Biotech Update- Revenge of the Pricing Questions
While I was expecting to talk a little about AGIO today, I want to go back to the macro sector sentiment as the proverbial hits keep on coming with ESRX making more noise about Sovaldi prices. In general, ESRX is arguing that GILD is going to bankrupt the entire healthcare system and that they will […]
April 7 Biotech Update- An Active AACR
So a lot to talk about and I will briefly touch on a lot and then expand later this week as I doubt many days will be a busy as today in term of news. The sector had a good morning but we have seen this before and at this point it will not be […]
April 4 Biotech Update
As often happens when you have small children the best laid plans are often disrupted. So I am taking care of a child with a suspected strep throat infection (the irony is certainly not lost on me given how much time I spend researching antibiotics and the companies that are developing new treatments) and this […]
March 25 Biotech Update- Would it Help to Cry Uncle?
Today certainly started as a better day in the sector but I would be careful of chasing this move. Ideally, we spend time building a base but a day or two of running is possible given the oversold conditions in the space. At this point I would lean towards the sector having put in a […]
March 24 Biotech Update- Being Kicked When You Are Down
Every sell off starts the bubble talk and the more severe the selling the more intense the bubble talk. What is interesting about this time is that the bubble talk has a broader audience as the sector seems to have been on more radars. As I have been saying for awhile, this sell off is […]
March 17 Biotech Update- Due for a Bounce?
The sector looked good this morning but seemed more in line with the broader market and not necessarily a signal of strength. We are at a region where we should see a bounce in the IBB but the move this morning was not really encouraging. It seemed that there were more than enough sellers on […]
March 7 Biotech Update- Selling Feeding Selling
I am going to spend today talking about the sector in general and send this note out early in light of the significant sell off that started yesterday afternoon and continued this morning. While the bulk of the discussion seemed to center on GILD it should be noted that it was the sector that got […]
February 28 Biotech Update- Whose Afraid of a Little Selling?
Well, it was a good day for the market and sector, although it seems to be getting weaker as the day goes on. I think we need to be careful going forward as we are getting towards a seasonally weak portion of the year and the sector has had a nice run and is looking […]
February 24 Biotech Update- Blowing Bubble Talk (Again)
The broader markets certainly started the week off strong and took the biotech sector with them. That being said I did not see any really strong outperformance. The large caps were up but generally in line with the broader market and small caps more or less the same. So I really see today’s move as […]
February 19 Biotech Update- Talking Gene Therapy
We have had a strong couple of days and clearly the biotech rally is in continuation mode but I still would not be surprised to see a day or two like today where it rests a little. Keep in mind that the IBB index is essentially an index of large cap biotechs and will move […]
IBB – In The Decision Zone
iShares Nasdaq Biotechnology (IBB) -Nasdaq The best indicator for our biotech portfolios are biotechnology indices such as IBB, NBI, XBI or XLV. By looking at the IBB daily chart, we get the whole picture of the latest epic run in the biotech sector during 2013, with a whopping run from 134.21 to 227.06 points, gaining 69.2%, while […]
Week’s Option Activity (7/29~8/2)
The following stocks had notable activity in their options during the past week: $IBB (7/30): 2,500 SEP 190.0/(180.0) strike Put spreads (ETF at $197) were bought for 2.30 or total debit of $575,000. The SEP 190.0 strike Puts were bought for 4.00 and the SEP 180.0 strike Puts were sold for 1.70 against. Buyer makes […]
IBB – Technical Commentary
iShares Nasdaq Biotechnology (IBB) – Nasdaq The best indicators for our biotech portfolio are the biotechnology indices IBB, NBI, XBI or XLV. After publishing “IBB – Biotechnology Index at All Times High“, we wanted to maintain our focus on the IBB. In today’s video “IBB – Market Activity” Tony noted a large bearish bet or hedge […]
IBB – Biotechnology Index at All Times High
Nasdaq Biotechnology Index Fund ETF (IBB) The best indicator for our biotech portfolio are the biotechnology indexes like IBB, NBI, XBI or XLV. Since we already published “The IBB and SPX In The Decision Zone“, we will maintain our focus on the IBB. By looking at the IBB daily chart, we get the whole picture […]
The IBB and SPX In The Decision Zone
In my previous report “IBB – A Closer Look at the Market’s Direction” I tried to find out if the markets bottomed out after the technical correction in the indices $IBB and $SPX, as both reached a support area, and the price found a support line around the Fibonacci 61.8% . Is it the bottom ? […]
IBB – A Closer Look at the Market’s Direction
In my previous report “IBB – Nasdaq Biotechnology Index – Reaching a Critical Point ” I tried to find out if the technical correction in the index $IBB reached a support area, and the price found a support line around the Fibonacci 61.8 or the weekly support line at 126.90 points. Today the price reached […]
IBB – Nasdaq Biotechnology Index – Reaching a Critical Point
iShares Nasdaq Biotechnology (IBB)-NasdaqGM Typically, the best indicator of the action in our biotech portfolio is the $IBB. By looking at it we get the whole picture of the pressure that we as investors or traders in the biotech sector have felt in the past 4 trading weeks after the euphoria and the hype that […]
